An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.

Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease. A triple drug combination of the anti-filarial drugs ivermectin, diethylcarbamazine (DEC) and albendazole (IDA) has been shown to be safe and effective for achieving sustained clearanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Taniawati Supali (Author), Yenny Djuardi (Author), Michael Christian (Author), Elisa Iskandar (Author), Rahmat Alfian (Author), Roospita Maylasari (Author), Yossi Destani (Author), Adriani Lomiga (Author), Dominikus Minggu (Author), Daphne Lew (Author), Joshua Bogus (Author), Gary J Weil (Author), Peter U Fischer (Author)
Format: Book
Published: Public Library of Science (PLoS), 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available